Molecular features of hypothalamic plaques in Alzheimer's disease.
about
Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disordersAlzheimer's disease related markers, cellular toxicity and behavioral deficits induced six weeks after oligomeric amyloid-β peptide injection in ratsFrontal Lobe Function and Risk of Hip Fracture in Patient With Alzheimer Disease: An Analysis of Linked DataReduced limbic and hypothalamic volumes correlate with bone density in early Alzheimer's diseaseInsulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOEɛ4 CarriersEffect of alanine replacement of l17 and f19 on the aggregation and neurotoxicity of arctic-type aβ40Alzheimer-associated Aβ oligomers impact the central nervous system to induce peripheral metabolic deregulation.Brain trauma induces massive hippocampal neuron death linked to a surge in beta-amyloid levels in mice overexpressing mutant amyloid precursor protein.Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques.Human apolipoprotein E4 targeted replacement in mice reveals increased susceptibility to sleep disruption and intermittent hypoxia.Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptidesTime-course and regional analyses of the physiopathological changes induced after cerebral injection of an amyloid β fragment in rats.Age-related changes in core body temperature and activity in triple-transgenic Alzheimer's disease (3xTgAD) miceSleep in Alzheimer's Disease - Beyond Amyloid.Challenges for Alzheimer's Disease Therapy: Insights from Novel Mechanisms Beyond Memory Defects.
P2860
Q24562763-C06FF902-73DB-4C30-AEBA-2BAC9882C199Q28484767-B64977C9-E2C2-4BD9-906A-D8D0A63F9DA3Q31021791-92A670D0-52EC-4E76-B82B-3CF8A297E1F6Q33944174-62C4F6B6-9210-4E80-A4C9-6688CEADA6F0Q34468797-51205105-138A-4A48-8C0E-E91C1B6C6B9AQ34698191-92255700-74D7-45C8-A966-A62CAC3909D2Q35084406-0069755A-544C-4289-B057-2FBED5294F17Q35753360-18410889-1502-457C-A19C-7D4E4B357DCBQ35782745-4B707E7C-4A91-40ED-87E2-67CAF9A97083Q36115297-ADA43E89-AB1B-4F18-91FB-D462040D8D3CQ36596465-F57984AC-EE06-44D7-AEA3-AD14E725A4ABQ42045019-26808530-DB36-4544-97A3-F0347F7BD179Q42073333-5A7C4B67-03ED-488B-9208-2FC0DE617DE4Q47586083-FBC8CB90-23AC-4113-B81E-142C783EF9AAQ50199042-B9105A91-487D-463C-960D-2988394A91C9
P2860
Molecular features of hypothalamic plaques in Alzheimer's disease.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Molecular features of hypothalamic plaques in Alzheimer's disease.
@ast
Molecular features of hypothalamic plaques in Alzheimer's disease.
@en
type
label
Molecular features of hypothalamic plaques in Alzheimer's disease.
@ast
Molecular features of hypothalamic plaques in Alzheimer's disease.
@en
prefLabel
Molecular features of hypothalamic plaques in Alzheimer's disease.
@ast
Molecular features of hypothalamic plaques in Alzheimer's disease.
@en
P2093
P2860
P1476
Molecular features of hypothalamic plaques in Alzheimer's disease
@en
P2093
B D Greenberg
D G Standaert
J Q Trojanowski
P2860
P304
P407
P577
1991-09-01T00:00:00Z